Robert B. Belshe, MD

St. Louis University School of Medicine
3691 Rutger
Suite 100
St. Louis, MO
USA 63110-2515
Email: belsherb@slu.edu

Biographical Sketch:
1989 Present Professor of Medicine, Pediatrics, and Molecular Microbiology Saint Louis University School of Medicine, St. Louis, MO 1989 Present Director, Division of Infectious Diseases and Immunology, Saint Louis University School of Medicine, St. Louis, MO 1995 Present Dianna and J. Joseph Adorjan Endowed Professor of Infectious Diseases and Immunology, Saint Louis University School of Medicine, St. Louis, MO 1986 1987 Visiting Scientist, National Institute for Medical Research, Medical Research Council, Mill Hill, London, UK, June 1986 - March 1987 1984 1989 Professor of Microbiology, Marshall University School of Medicine, Huntington, WV 1984 1985 Acting Chairman, Department of Medicine, Marshall University School of Medicine 1980 1984 Associate Professor of Microbiology, Marshall University School of Medicine, Huntington, WV 1978 1989 Chief of the Section of Infectious Diseases, Marshall University School of Medicine, Huntington, WV 1983 1989 Professor of Medicine, Marshall University School of Medicine, Huntington, WV 1978 1983 Associate Professor of Medicine, Marshall University School of Medicine, Huntington, WV 1977 1978 Medical Officer, USPHS, National Institutes of Health, NIAID, LID, Bethesda, MD 1975 1977 Research Associate, USPHS, National Institutes of Health, NIAID, LID, Bethesda, MD 1975 1978 United States Public Health Service Clinical and laboratory research interests include the development of live attenuated respiratory virus vaccines, such as respiratory syncytial virus, parainfluenza, and influenza. Organized and chaired several large pivotal efficacy trials of influenza vaccines for the NIH and industry. Served on FDA and CDC advisory committees pertaining to vaccine regulatory matters and assisted in developing vaccine usage guidelines and recommendations. Currently chairs the Herpevac Trial For Women, an ongoing NIAID study of HSV-2 vaccine in women. Scholarly contributions include more than 200 publications to journals such as The New England Journal of Medicine and JAMA, as well as numerous presentations at scientific meetings.